Curetis AG

Curetis AG, founded in August 2007, is a privately held molecular diagnostic company focusing on the development and commercialization of reliable, fast and cost-effective tools for diagnosing severe infectious diseases.

Curetis develops a miniaturized, fully integrated molecular diagnostic solution based on a universal instrument platform and disease-specific disposables, complemented by an integrated information management system. This will enable multiparameter pathogen and antibiotic resistance detection in only a few hours, a process that today can take up to days or even weeks with current methods.

Use the following links for details on the management team and to learn more about Curetis product features.